{"lastClose": 3.9600000381469727, "len": 1008, "date": "2023-04-04", "alpha_1": -0.8120453338767861, "beta_1": 0.8221723941901705, "drawup_1": 0.7155424508464454, "natr_1": 19.73975392212758, "sup_1": -0.026599325058683482, "res_1": 0.26195283839723954, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 39.0977464725107, "adx_1": 36.517760321219164, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.9060729078984638, "stratHoldAlpha_1": 250.2736496639717, "stratHoldDrawdown_1": -0.7280049875072938, "alpha_3mo": -0.7844054519578574, "beta_3mo": 1.3116354645787804, "drawup_3mo": 0.1273486718940231, "natr_3mo": 19.73975392212758, "sup_3mo": -0.14898989594915615, "res_3mo": 0.035353521366117496, "bullPattern_3mo": [], "bearPattern_3mo": ["BELTHOLD", "CLOSINGMARUBOZU", "ENGULFING", "LONGLINE", "MARUBOZU"], "rsi_3mo": 54.70588342541196, "adx_3mo": 15.416171220066506, "drawdown_3mo": -0.31111111797913593, "stratHoldSharpe_3mo": -1.3919721876214988, "stratHoldAlpha_3mo": 250.37585110559218, "stratHoldDrawdown_3mo": -0.2831991078581432, "Name": "NGM Biopharmaceuticals Inc.", "Market Cap": 324943736, "Sector": "Health Care", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2019.0, "Country": "United States", "alpha%_1": 0.0058739816574017445, "beta%_1": 0.3742458958643331, "drawup%_1": 0.6710241756453121, "natr%_1": 0.9999999999367598, "drawdown%_1": 0.012795792901386759, "stratHoldSharpe%_1": 0.13757741107147442, "stratHoldAlpha%_1": 0.004761569351200526, "stratHoldDrawdown%_1": 0.01345616082091197, "alpha%_3mo": 0.12150717252763282, "beta%_3mo": 0.6696551017766255, "drawup%_3mo": 0.30955383294563377, "natr%_3mo": 0.9999999998455421, "drawdown%_3mo": 0.16381805896829393, "stratHoldSharpe%_3mo": 0.18118752408939004, "stratHoldAlpha%_3mo": 0.13190740482362134, "stratHoldDrawdown%_3mo": 0.16525567139542818}